MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.xkme.2023.100684

Медицинская библиотека · Kidney medicine · 2023

Frailty and Clinical Outcomes in Patients Treated With Hemodialysis: A Prospective Cohort Study.

Tonelli Marcello, Wiebe Natasha, Gill John S, Bello Aminu K, Hemmelgarn Brenda R, Chan Christopher T, Lloyd Anita, Thadhani Ravi I, Thompson Stephanie

СтатьяПеревод в очереди

Аннотация

RATIONALE AND

OBJECTIVE

Frailty is common among people with kidney failure treated with hemodialysis (HD). The objective was to describe how frailty evolves over time in people treated by HD, how improvements in frailty and frailty markers are associate with clinical outcomes, and the characteristics that are associated with improvement in frailty.

STUDY

DESIGN

Prospective cohort study.

SETTING AND

PARTICIPANTS

Adults initiating thrice weekly in-center HD in Canada.

EXPOSURE: We classified frailty using a 5-point score (3 or more indicates frailty) based on physical inactivity, slowness or weakness, poor endurance or exhaustion, and malnutrition. We categorized the frailty trajectory as never present, improving, deteriorating, and always present.

OUTCOMES: All-cause death, hospitalizations, and placement into long-term care.

ANALYTICAL APPROACH: We examined the association between time-varying frailty measures and these outcomes using Cox and negative binomial models, after adjustment for potential confounders.

RESULTS

985 participants were included and followed up for a median of 33 months; 507 (51%) died, 761 (77%) experienced ≥1 hospitalization and 115 (12%) entered long-term care. Overall, 760 (77%) reported frailty during follow-up. Three-quarters (78%) of those with frailty at baseline remained frail throughout the follow-up, 46% without baseline frailty became frail, and 23% with baseline frailty became nonfrail. Higher frailty scores were associated with an increased risk of mortality (fully adjusted HR, 1.58 per unit; 95% CI, 1.39-1.80) and an increased rate of hospitalization (RR, 1.16 per unit; 95% CI, 1.09-1.23). Compared with those who were frail throughout the follow-up, participants with frailty at baseline but improving during follow-up showed a lower mortality (HR, 0.59; 95% CI, 0.42-0.81), and a lower rate of hospitalization (RR, 0.70; 95% CI, 0.56-0.87).

LIMITATIONS: There was missing data on frailty at baseline and during follow-up.

CONCLUSIONS

Frailty was associated with a higher risk of poor outcomes compared with those without frailty, and participants whose status improved from frail to nonfrail showed better clinical outcomes than those who remained frail. These findings emphasize the importance of identifying and implementing effective treatments for frailty in patients receiving maintenance HD.

Для цитирования: Tonelli Marcello, Wiebe Natasha, Gill John S, Bello Aminu K, Hemmelgarn Brenda R, Chan Christopher T, Lloyd Anita, Thadhani Ravi I, Thompson Stephanie. Frailty and Clinical Outcomes in Patients Treated With Hemodialysis: A Prospective Cohort Study.. Kidney medicine. 2023. DOI: 10.1016/j.xkme.2023.100684.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.